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Induction of the vascular endothelial growth factor pathway in the brain of adults with fatal
falciparum malaria is a non-speciﬁc response to severe disease
Aims: Pathological or neuroprotective mechanisms in
the brain in severe malaria may arise from microvas-
cular obstruction with malaria-parasitized erythro-
cytes. This study aimed to investigate the role of
hypoxia and induction of the vascular endothelial
growth factor (VEGF) pathway in the neuropathophy-
siology of severe malaria.
Methods and results: Immunohistochemistry was per-
formed on post mortem brain tissue sections from 20
cases of severe malaria and examined for the expression
of transcriptional regulators of VEGF [hypoxia-induc-
ible factor-1 alpha (HIF-1a), HIF-2a], DEC-1, VEGF,
VEGF receptors 1 and 2, and the activated, phosphor-
ylated VEGF receptor 2 (pKDR). HIFs showed limited
protein expression and ⁄ or translocation to cell nuclei
in severe malaria, but DEC-1, which is more stable and
regulated by HIF-1a, was observed. There was heter-
ogeneous expression of VEGF and its receptors in severe
malaria and non-malarial disease controls. pKDR
expression on vessels was greater in malaria cases
than in controls but did not correlate with parasite
sequestration. VEGF uptake by malaria parasites was
observed.
Conclusions: VEGF and its receptor expression levels in
severe malaria reﬂect a non-speciﬁc response to severe
systemic disease. Potential manipulation of events
at the vasculature by the parasite requires further
investigation.
Keywords: cerebral, hypoxia, immunohistochemistry, malaria, pathophysiology, Plasmodium falciparum
Abbreviations: CM, cerebral malaria; CSF, cerebrospinal ﬂuid; EPO, erythropoietin; HIF, hypoxia-inducible factor;
pKDR, phosphorylated VEGFR2; PRBC, parasitized red blood cells; VEGF, vascular endothelial growth factor;
VEGFR, VEGF receptor; WHO, World Health Organization
Introduction
Falciparum malaria, a mosquito-borne disease caused
by the protozoan parasite Plasmodium falciparum,
remains a major global health problem, causing an
estimated 1–2 million deaths each year worldwide. A
common and frequently lethal manifestation of severe
malarial disease is cerebral malaria (CM), characterized
by decreased consciousness, coma and ﬁtting, which
resembles a metabolic or anaesthetic encephalopathy.
1
The overall mortality of adult CM is about 15–20% but
depends on associated vital organ dysfunction. In
patients with ‘pure’ CM and no other complications
of severe malaria the mortality is 8%, which rises
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acidosis. Most deaths occur within 48 h of admission.
Full recovery of consciousness takes a median of 2 days
in patients with a Glasgow coma score of <11, but
occasional adult patients may take >1 week to recover
consciousness.
2 It has been suggested that coma may
be neuroprotective. Neurons stressed by an inadequate
supply of oxygen and nutrients, and an unfavourable
metabolic milieu, may protect themselves by reducing
energy demands. Premature reversal of coma might
therefore increase the risk of neuronal damage.
3
The histopathological hallmark of CM is engorge-
ment of cerebral capillaries and venules with parasit-
ized red blood cells (PRBC) and non-parasitized RBCs.
Our studies of the pathology of CM in southeast Asian
adults indicate that sequestration of P. falciparum-
infected red blood cells in the microvessels of the brain,
and resulting microvascular obstruction, is a key
initiating factor in pre-mortem coma.
4–6 Understan-
ding how sequestration initiates coma, and subsequent
neuropathological processes occurring in the brain,
presents an important question in the search for
adjuvant therapy in severe disease. It is also likely that
a number of systemic factors, such as immune
responses or metabolic changes due to systemic effects
of disease, may modulate or contribute to coma and
neuropathological injury (reviewed in
7). However,
from our comparative studies in human immunodeﬁ-
ciency virus encephalitis and progressive multifocal
leukoencephalopathy,
8 it is clear that the amount of
tissue destruction and inﬂammation is considerably less
in adult southeast Asian CM patients. A potential
survival strategy of the parasite would be to limit the
amount of vascular damage that would attract inﬂam-
matory cells and subsequently harm developing
gametocytes present within the sequestered vessel.
The relationship between parasite sequestration,
signalling events across the blood–brain barrier and
subsequent neuropathological or protective responses
within the brain parenchyma in severe malaria is
poorly understood. Considering the prominent vascular
obstruction it is unclear why there is not more
irreversible injury and inﬂammation. One hypothesis
is that parasite sequestration in cerebral microvessels
leads to local hypoxia and increased expression of
hypoxia-inducible gene products such as vascular
endothelial growth factor (VEGF) and its receptors.
The VEGF signalling pathway is known to activate a
range of signals that are cytoprotective, angiogenic,
and neurotrophic.
9 Two studies examining serum and
cerebrospinal ﬂuid (CSF) levels of VEGF have recently
been reported in African children with malaria. One
study of a small group of Ghanaian children (n = 19)
showed no difference between CM, severe malarial
anaemia and non-malarial disease at the time of
death.
10 In a study of Kenyan children (n = 124),
serum and CSF levels of VEGF were not associated with
the development of neurological sequelae but, rather,
features associated with a poor outcome such as
seizures, raised intracranial pressure and papilloedema.
11
Serum VEGF levels were investigated in adult and
paediatric patients from India, of whom 25 were
healthy controls, 48 had mild malaria and 60 had
CM (48 survived and 12 died).
12 CM patients who died
had a signiﬁcantly lower level of VEGF compared with
the other patient groups, which led to the authors to
suggest that VEGF should be considered for adjunctive
therapy to improve the treatment outcome in CM. In a
more recent study of 146 adults from Papua Indonesia
there were no associations between elevated VEGF
concentrations and disease severity or a poor out-
come.
13 In this study plasma VEGF levels were lower in
severe malaria compared with patients with moder-
ately severe malaria or healthy controls and VEGF was
inversely associated with lactate.
13
Only two studies have investigated VEGF protein
expression in the brain of severe or CM cases.
14,15 In
the ﬁrst study, immunohistochemical analysis of VEGF
was carried out in the brain of six European adults who
had died from CM.
14 VEGF was found in astrocytes and
VEGF receptor 1 (VEGFR1; ﬂt-1) in Du ¨rck’s granulo-
mas. Localization of KDR and the extent of receptor
activation and phosphorylation were not determined.
The more recent study by our group
15 showed the
unexpected ﬁnding of VEGF immunolabelling by
sequestered malaria parasites. Although parasite
immunolabelling was not reported in the ﬁrst study,
we believe the ﬁndings to be of signiﬁcance. VEGF
uptake was conﬁrmed in vitro
15 and in a clinical study
by Yeo et al.
13 an inverse association was observed
between plasma VEGF concentrations and parasite
biomass, suggesting potential manipulation of the host
response to malaria infection by the parasite.
The aims of this study were to deﬁne the endogenous
expression of VEGF and its (activated) receptors in the
brain of cases of fatal severe malaria and to identify
potential systemic and local regulatory factors. Com-
parisons were made with a group of control cases
characterized by non-infectious, multi-organ failure to
ensure differentiation of features speciﬁc to malaria
compared with a background of agonal neuropathol-
ogy. Hypoxia and the transcriptional complex hypoxia-
inducible factor (HIF) are key regulators of VEGF, so we
have investigated the protein expression of HIF-1a and
HIF-2a. However, due to the short half-lives of HIFs
(a few minutes under normoxia) we have also inves-
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tein, DEC-1, which is also induced by hypoxia and HIF-
1a but has an estimated half-life of 30 h. In light of the
ﬁndings of VEGF uptake by parasites we have investi-
gated whether this could affect protein expression levels
or the abundance of receptors at the vasculature or
within the brain parenchyma. Treating patients with
exogenous VEGF may exacerbate inﬂammation and
provide trophic support for the parasite that could
potentially worsen the treatment outcome in adults
with CM.
Materials and methods
case selection
Autopsy brain specimens were taken from adult
patients who had died of severe falciparum malaria
on the Malaria Ward, Centre for Tropical Diseases (Ho
Chi Minh City, Vietnam), as described previously.
16
These patients were divided into two groups: CM
(n = 7) and non-CM (n = 13). CM was deﬁned accord-
ing to World Health Organization (WHO) guidelines on
the basis of a Glasgow coma score of £11,
3 other causes
of unconsciousness having been excluded (e.g. hypo-
glycaemia, meningitis or other encephalopathy), by
clinical, biochemical and CSF examination. Non-CM
patients were those dying from severe malaria without
coma, who had a range of clinical features typical of
other vital organ system complications.
Control cases were from different causes of death in
patients undergoing autopsies at the John Radcliffe
Hospital (Oxford, UK). Control sections used to assess
the protein expression of VEGF and its receptors in
brain came from fatal cases with multi-organ dysfunc-
tion that did not have obvious structural neuropathol-
ogy on standard histological examination (see Table 1).
Positive controls for HIF immunostaining included
sections of clear cell carcinoma and global hypoxic-
ischaemic injury. Positive controls for VEGF and its
receptors included sections of normal ovary. Protocols
for tissue sampling, storage and use were approved by
the Ethical and Scientiﬁc Committee of the Centre for
Tropical Diseases, Vietnam, OXTREC 029-02, COREC
(C01.002) and the Human Tissue Authority license
number 12217.
immunohistochemistry
Three areas of the brain were examined to judge the
patterns of histological immunoreactivity. These in-
cluded sections from cortex (temporal), diencephalon
(or interbrain) situated between the cerebrum and
brainstem including the thalamus and projections of
the internal capsule, and brainstem (medulla). Immuno-
histochemistry was performed with multiple antibodies,
with varying methods of antigen retrieval, as detailed
in Table 2. The conditions and dilutions of antibodies
were optimized in previous experiments or according to
manufacturers’ instructions. All sections were from
formalin-ﬁxed parafﬁn-embedded blocks, which were
deparafﬁnized and re-hydrated using graded alcohols to
water, and immunostained according to standard
protocols. Negative controls included omission of
primary and secondary antibodies.
semiquantification
The sections were scored using a semiquantitative
system based on the frequency of reactivity of individ-
ual parenchymal elements or vessels: no reactivity ()),
<1% cells reactive (+), 1–10% cells reactive (++),
Table 1. Control patient data
Patient Clinical history
MODC1 Pneumonia, pulmonary embolus, deranged blood clotting (International normalized ratio >15), peripheral
vasculopathy (critical ischaemia of both feet), renal failure, cardiac arrest due to left ventricular
myocardial infarction
MODC2 Rheumatoid arthritis, non-insulin-dependent diabetes mellitus, gastric ulcer, anaemia, heart failure,
bilateral bronchopneumonia, preterminal shock with pulmonary oedema and acute tubular necrosis
MODC3 Congestive cardiac failure, acute myocardial infarction, severe generalized atherosclerosis,
deteriorating renal function prior to death
MODC4 Empyema, bronchopneumonia and pleural ﬁbrosis
MODC5 Renal transplant, circulatory collapse due to acute ruptures, aortic dissection with pleural and
pericardial haematoma
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the scoring over a conference microscope. Evaluation of
HIF-1a and HIF-2a was based on the frequency of
nuclear and cytoplasmic reactivity,
17 since previous
studies in cancer tissue have shown that the prognostic
relevance of a scoring system based on nuclear HIF
expression alone was very poor compared with a
scoring system that also takes strong cytoplasmic
reactivity into account.
18 DEC-1 score was based on
the frequency of nuclear immunoreactivity.
18 The
score for VEGF and its receptors was based on
cytoplasmic and plasma membrane reactivity.
Identiﬁcation of the cellular expression of markers
was based on nuclear morphological and dimensional
characteristics, as follows. Brieﬂy, neurons were iden-
tiﬁed in the grey matter by their large nuclei and
prominent nucleolus as well as pigment granules,
Nissl’s substance or lipofuscin within the cytoplasm.
Glia were distinguished from neurons by nuclear
phenotype. In general, glial nuclei are smaller, lack
nucleoli but often contain clumps of heterochromatin
and frequently are found in a satellite position. Blood
vessels were identiﬁed by their narrow tubular
proﬁles. Layers of the vessel walls could be clearly
identiﬁed using counterstains with endothelial cells
providing the innermost layer and smooth muscle
cells, pericytes and perivascular macrophages in the
surrounding layers.
clinicopathological correlation
The patterns and intensity of immunoreactivity in
different cellular groups (as deﬁned above) were corre-
lated with pre-mortem clinical information, including
the incidence of systemic and local neurological com-
plications of severe malaria infection before death.
These included whether or not the patient suffered from
CM before death and the other major systemic compli-
cations deﬁning severe malaria according to the WHO
criteria,
3 such as anaemia (haematocrit <20% plus
parasitaemia >100 000 ll, haemodynamic shock (sys-
tolic blood pressure <80 mmHg), pulmonary oedema,
hypoglycaemia (plasma glucose <2.2 mmol ⁄ l), jaun-
dice (bilirubin >2.5 mg ⁄ dl) or acute renal failure
(plasma creatinine >3 mg ⁄ dl). Data were analysed
using non-parametric tests (Kruskall–Wallis test,
Spearman rank correlation and Fisher’s exact test).
No adjustments for multiple comparisons were made,
although, for the purposes of interpretation and
discussion, P < 0.01 was regarded as signiﬁcant.
Table 2. Details of the antibodies, dilutions, and antigen retrieval methods used in this study
Primary antibody Speciﬁcity Antigen retrieval
Dilution ⁄
incubation time Source Reference
ESEE 122 HIF-1a 0.1 M EDTA
3 min, PC
Neat
90 min, RT
In house 27
EP 190b HIF-2a 0.1 M EDTA
60 C, ON
Neat
90 min, RT
In house 27
CW27 DEC-1 Citrate buffer
10 min, MW
1:1000
45 min, RT
Prof. Adrian Harris,
CRUK
18
VG-1 VEGF 0.05 M
Tris ⁄ 0.2 mM EDTA
3 min, PC
1:4, 90 min, RT In house 28
C-17 VEGF-R1 As above 1:200
90 min, RT
Santa Cruz, CA
Y-23 VEGF-R2 As above 1:200
90 min, RT
Santa Cruz, CA
pKDR34 pKDR Citrate buffer
3 min, MW
1:5
90 min, RT
In house 29
All primary antibodies were visualized with the Envision-HRP ⁄ AP kits (Dako, Ely, UK) with the exception of ESEE 122, which
was visualised with the TSA-HRP kit (NEN, Boston, MA, USA).
EDTA, ethylenediamine tetraaceticacid; ON, overnight; RT, room temperature; PC, pressure cooker; MW, microwave; CRUK,
Cancer Research, UK.
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transcription factors
HIF-1a and HIF-2a
Strong up-regulation of nuclear HIF-1a in peritumoral
and intratumoral macrophages was observed in the
positive control case of renal clear cell carcinoma
(Figure 1A). Up-regulation of nuclear and cytoplasmic
HIF-1a was also observed in brain tissue from a
fatal case of diffuse ischaemic-hypoxic injury with a
prolonged period of perioperative hypoxia. Immuno-
reactivity for nuclear or cytoplasmic HIF-1a was not
observed in any of the malaria cases (Figure 1E).
Strong nuclear and cytoplasmic immunoreactivity
was observed for HIF-2a in positive control sections
(Figure 1B–D).HIF-2areactivitywasobservedinatleast
one brain region of all severe malaria cases. Reactivity
was predominantly cytoplasmic, although occasional
HIF-2a-labelled nuclei were observed (Figure 1F). There
was a signiﬁcant increase in the frequency of HIF-2a
protein expression associated with the vasculature
(including endothelial cells, pericyte ⁄ smooth muscle
cells and astrocyte endfeet), relative to the non-neuro-
logical, multi-organ dysfunction control cases from the
UK (referred to as the ‘controls’ for the remainder of the
Results section: all brain regions, P = 0.005; cortex,
P = 0.005; diencephalon, P = 0.007; brainstem,
P = 0.01). However, within the severe malaria group
there was no difference in the frequency of HIF-2a
associated with the vasculature between brain regions
or between CM and non-CM cases.
There was no signiﬁcant increase in the frequency of
nuclear and ⁄ or cytoplasmic HIF-2a protein expression
in neurons or glia, relative to controls. Within the
severe malaria group there was more HIF-2a found in
glia in the cortex compared with the brainstem
(P = 0.005), but there was no difference in the
frequency of HIF-2a in neurons between brain regions.
There was no signiﬁcant difference in HIF-2a in
neurons or glia between CM and non-CM cases.
DEC-1 (SHARP2, Stra13)
Endothelial cells (Figure 1G), glia and neurons
(Figure 1H) displayed nuclear accumulation of DEC-1
in sections from severe malaria cases (Figure 2) and the
controls. There was a trend for an increased frequency
of nuclear DEC-1 protein expression in neurons in
severe malaria, relative to controls (P = 0.03), but this
was not the case for glia or vessels. There was no
signiﬁcant difference in nuclear DEC-1 in neurons, glia
or vessels between CM and non-CM cases.
vascular endothelial growth factor
and its receptors
VEGF, VEGFR1 (ﬂt-1), VEGFR2 (ﬂk-1) and phosphor-
ylated VEGFR2 (pKDR) were expressed in both control
and severe malaria cases. Expression was associated
with vessels, glia and neurons (Figures 2–4).
VEGF
Both control brain and severe malaria sections showed
a high but heterogeneous frequency of protein expres-
sion for VEGF, particularly in neurons (Figures 2 and
4A,B,E). There was no signiﬁcant increase in the
frequency of cytoplasmic VEGF protein expression of
neurons, glia or vessels in severe malaria, relative to
the controls.
Within the severe malaria group there was a
signiﬁcant difference in cytoplasmic accumulation of
VEGF in neurons between brain regions (P = 0.005),
with a lower frequency found in the cortex compared
with the brainstem (P = 0.003), and a similar trend
was found in the cortex and the diencephalon
(P = 0.04) but not between diencephalon and brain-
stem (P = 0.15). In contrast, there was no signiﬁcant
difference in the frequency of VEGF protein expression
associated with glia or the vasculature between brain
regions. There was no signiﬁcant difference in VEGF in
neurons, glia or the vasculature between CM and non-
CM cases.
Of interest, we also noted intense immunoreactivity
of sequestered P. falciparum-infected erythrocytes by
VEGF (Figure 4). Of the severe malaria cases, 10 (50%)
could be adequately assessed for VEGF reactivity
associated with parasite sequestration. Careful exam-
ination under oil showed VEGF reactivity in 6 ⁄ 10
Figure 1. Hypoxia-inducible factor (HIF)-1a, HIF-2a and DEC-1 immunoreactivity of post mortem brain tissue of positive controls (peroxidase,
brown) and severe malaria cases (alkaline phosphatase, red). A, Nuclear reactivity for HIF-1a in a renal clear cell carcinoma. B, Nuclear and
cytoplasmic reactivity for HIF-2a in the same renal tumour. C, HIF-2a reactivity in a case of generalized hypoxic-ischaemic injury. In the
cerebellum there is strong reactivity of HIF-2a on macrophages and glial cells around the depths of the sulci. D, HIF-2a reactivity surrounding a
metastatic deposit of adenocarcinoma in the brain. Peritumoral macrophages show strong immunopositivity. E, HIF-1a is not observed on any of
the sections from severe malaria cases. F, Nuclear and cytoplasmic HIF-2a is observed at low levels in at least one brain region of all severe
malaria cases. G, DEC-1 reactivity of endothelial cells in a positive control case with infarction. H, Nuclear DEC-1 reactivity in neurons and glial
cells in a severe malaria case.
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surrounding red cell membrane. This was seen in
both CM and non-CM cases. Although other controls
showed reactivity of plasma proteins in the vascular
space, this pattern appeared speciﬁc. Not all cases of
malaria showed VEGF immunoreactivity of parasites,
and within positive cases not all parasites were
reactive. More recently, this ﬁnding has been conﬁrmed
in cultured parasites, as reported elsewhere.
15 In all but
one case, VEGF+ parasites were observed in sections
with high sequestration rates, i.e. >50% vessels
sequestered [median (interquartile range) cortex: 94%
(89–95%); diencephalon: 71% (70–90%); brainstem:
55% (50–84%)]. Sections containing parasites without
VEGF labelling had a lower median percent sequestra-
tion rate [cortex: 45.5% (16.5–67.5%); diencephalon:
32.5% (3.5–65%); brainstem: 19.5% (6–44.5%)]. Only
cortex showed a statistically signiﬁcant difference
between parasite sequestration rate with VEGF-labelled
parasites compared with VEGF
) parasites, despite a
similar trend in other brain areas (cortex P =
0.01; diencephalon P = 0.16; brainstem P = 0.24;
Figure 4).
VEGF receptor 1 (ﬂt-1)
There was a signiﬁcant increase in the frequency of
ﬂt-1 protein expression in neurons in brainstem
(P = 0.004), relative to controls. However, there was
no signiﬁcant increase in the frequency of ﬂt-1 protein
expression associated with glia or the vasculature
relative to controls.
Within the severe malaria group there was a
signiﬁcant difference in ﬂt-1 in neurons with a lower
frequency found in the diencephalon compared with
the brainstem (P = 0.001) but not between cortex and
brainstem (P = 0.22) or cortex and diencephalon
(P = 0.13). In contrast, there was no difference in ﬂt-
1 in glia or the vasculature between brain regions.
There was no signiﬁcant difference in ﬂt-1 in neurons,
glia or the vasculature between CM and non-CM cases.
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Figure 2. Frequency of immunoreactivity for markers in the brain of fatal cases of severe malaria. The degree of reactivity per tissue section was
semiquantiﬁed using the following scale: 0, no reactivity; 1, <1% of cells ⁄ vessels reactive; 2, 1–10% of cells ⁄ vessels reactive; 3, >10%
cells ⁄ vessels reactive. Each score represents the average of results from three brain regions including the temporal cortex, diencephalon
(thalamus, projections of internal capsule) and medulla of the brainstem for an individual patient. *Statistically higher median levels in the severe
malaria group compared with non-neurological controls from the UK with multi-organ dysfunction.
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vegf receptor 2 (pKDR)
Flk-1 and pKDR were found in parenchymal neurons,
glia and associated with the cerebral vasculature in
sections from severe malaria cases (Figures 2 and 3C–I)
andcontrols.pKDRwasalsofoundonaxons(Figure 3H,
axons in longitudinal section, black arrows; Figure 3I,
axonsincrosssection,whitearrows)andperiaxonalglia
following axonal tracts (Figure 3E,G).
There was no signiﬁcant increase in the frequency of
ﬂk-1 protein expression associated with neurons, glia
or the vasculature relative to controls (Figure 2).
Within the severe malaria group there was a signiﬁcant
difference in ﬂk-1 in neurons between brain regions,
with a higher frequency found in the brainstem
compared with the cortex (P = 0.0001) and dienceph-
alon (P = 0.007), but not between cortex and dien-
cephalon (P = 0.16). In contrast, within the severe
malaria group there was no signiﬁcant difference in
ﬂk-1 protein expression associated with glia or the
vasculature between brain regions.
Similarly, there was no signiﬁcant increase in the
frequency of pKDR protein expression associated with
neurons and glia, relative to controls. However, there
was a signiﬁcant increase in the frequency of pKDR
protein expression associated with the vasculature
relative to controls when all brain regions were con-
ABC
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Figure 3. Vascular endothelial growth factor (VEGF), VEGF receptor 1 and activated VEGF receptor 2 (KDR) immunoreactivity in post mortem
braintissue of severe malaria cases and controls. A, A vessel with endothelial cells expressing VEGF (arrows). B, Endothelial cells, perivascularcells
and neurons labelled for VEGF receptor 1. C, Neuronal and glial labelling for activated KDR. D–F, Different paravascular patterns of
immunoreactivity for activated KDR: diffuse (D); following white matter tracts (E); glial-associated (arrows, F). G–I, Activated KDR reactivity
associated with axonal ﬁbre tracts: longitudinal section showing peri-axonal glial reactivity (arrows) in a severe malaria case (G); longitudinal
section showing axonal reactivity (arrows) in a case with cerebral infarction (H); transverse section showing axonal reactivity (white arrows)
in close proximity to a vessel also showing KDR reactivity of endothelial cells (black arrows) and pericyte ⁄ smooth muscle cells in a severe
malaria case.
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but not in the cortex (P = 0.56) or diencephalon
(P = 0.07). Within the severe malaria group there was
no signiﬁcant difference in pKDR protein expression
associated with neurons or glia between brain regions.
In contrast, there were signiﬁcant differences in pKDR
protein expression associated with the vasculature
between brain regions, with a greater frequency of
immunoreactivity in the brainstem compared with
cortex (P = 0.0001) and diencephalon (P = 0.0001),
but not between the cortex and diencephalon
(P = 0.10). There was no signiﬁcant difference in pKDR
expression in neurons, glia or the vasculature between
CM and non-CM cases.
clinicopathological correlations
To investigate the signiﬁcance of these patterns of
marker expression, we performed a detailed clinico-
pathological correlation between the frequency of
marker expression associated with the vasculature,
glia and neurons within individual brain regions and
the presence of a number of clinical and biochemical
parameters using all malaria patients.
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Figure 4. A, A vessel containing sequestered malaria parasites that are strongly positive for vascular endothelial growth factor (VEGF). Neurons
are also immunolabelled for VEGF in this section (*). B, A vessel containing parasites that are VEGF+ (ﬁlled arrow). An adjacent vessel with
parasites that are not positive for VEGF (empty arrow). This vessel shows light labelling for VEGF on the endothelial cells. Neurons (*) and glia
(arrowheads) are also labelled for VEGF in this section. C, Graph showing percent sequestration (% vessels with parasite sequestration) in the
cortex, diencephalon and brainstem with and without VEGF-labelled parasites. In all but one case, VEGF+ parasites are observed in sections with
high sequestration rates. D, A large vessel containing numerous intravascular leucocytes. VEGF-labelled parasites appear cytoadhered to the
endothelium. Interaction between the endothelium, parasites and monocytes can be observed (see insert, 317% enlargement). Light labelling of
the endothelium can be observed in several segments of the vessel (arrows). E, A large vessel without intravascular parasites shows strong
reactivity for VEGF on endothelial cells and pericytes. The serum is also immunolabelled for VEGF. A smaller vessel in the bottom left corner of
the image shows VEGF labelling on perivascular glia (arrowheads). VEGF+ neurons can also be observed (*).
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markers and hypoxia, the initial analysis focused on
complications of malaria infection that may lead to
hypoxic damage to the brain and markers of hypoxia.
These included percentage of vessels sequestered in the
brain, admission peripheral parasite count, hyperpara-
sitaemia, admission ⁄ minimum haematocrit ⁄ anaemia
and plasma lactate, haemodynamic shock, and pulmo-
nary oedema.
Positive correlations were found between the per-
centage of vessels sequestered and the frequency of
HIF-2a labelling associated with the vasculature in the
brainstem (P = 0.01, r = 0.55) and when HIF-2a was
expressed as a whole brain average (P = 0.002,
r = 0.64). There was a trend in the diencephalon
(P = 0.07) but no correlation in the cortex (P = 0.33).
Additional parameters analysed included the time to
death from admission; plasma levels of glucose; CSF
opening pressure, protein and white cell count; and
measures of multi-organ disease, in addition to those
described above, including jaundice, and acute renal
failure. Negative correlations were found between
admission plasma glucose levels and frequency of
HIF-2a labelling associated with the vasculature in
the diencephalon (P = 0.009, r = )0.61) and when
HIF-2a was expressed as a whole brain average (P =
0.002, r = )0.67). There was a trend in the brainstem
(P = 0.02) but no correlation in the cortex (P = 0.11).
There were no correlations between admission plasma
glucose and percent parasite sequestration in the
brain (P > 0.2, for each individual brain area). There
were no other statistically signiﬁcant correlations on
univariate analyses.
Discussion
The aims of this study were to deﬁne the endogenous
expression of VEGF and its receptors in the brain of
cases of fatal severe malaria and identify potential
systemic and local regulatory factors. Attempts were
made to guard against over-interpretation of our data,
by examining changes in malaria cases in comparison
with UK control cases who died with multi-organ
dysfunction but without structural damage to the brain
on standard neuropathological examination.
In severe malaria, the importance of tissue hypoxia is
reﬂected in the consistent observation of elevated
concentrations of lactate in plasma on admission, with
an increased lactate:pyruvate ratio.
19 Degradation of
HIF-1a under normoxia and its stabilization in hypoxia
constitutes a major cellular response during the tran-
sition from ambient to low oxygen tension. During
normal oxygen supply, HIF-1a is hydroxylated by
oxygen-dependent prolyl-4-hydroxylases, ubiquinated
and rapidly degraded by the proteosomal system.
HIF-1a immunoreactivity of cellular nuclei is thereby
often used as a marker of hypoxia. It is also clear
that there is heterogeneity in adaptation of altered
oxygen tensions between cell types via HIF. For
example, an in vitro study of how hypoxia affects
astrocyte survival demonstrated that HIF-1a protein
stabilization occurs only after severe oxygen depri-
vation of near anoxic (<0.1% O2) levels and subse-
quent reoxygenation (21% O2) for 5 h abrogated
protein stabilization.
20 Another study demonstrated
minimal HIF-1a protein stabilization in neurons under
hypoxic conditions (1% O2) with glucose deprivation
and a high level of reactive oxygen species (oxidizing
environment), which are likely to coincide when there
is cerebral ischaemia with disturbed glucose supply and
consumption.
21
In the current study there was strong nuclear
immunoreactivity for HIF-1a and HIF-2a in the control
tumour cases and brain tissue from a fatal diffuse
ischaemic-hypoxic injury. No reactivity for HIF-1a was
observed in any of the malaria cases despite multiple
attempts using different protocols and antibodies, and
despite very good control staining. It therefore appears
that widespread persistent stabilization of HIF-1a is
not occurring in severe malaria cases. HIF-2a was
found at a greater frequency in the vasculature in
severe malaria cases compared with non-neurological
controls. However, immunolabelling was predomi-
nantly found in the cytoplasm, suggesting protein
stabilization but a lack of transportation to the site of
action. Nevertheless, there was a positive correlation
between the percentage of vessels sequestered and a
negative correlation with admission plasma glucose
levels with the frequency of HIF-2a labelling associated
with the vasculature. These ﬁndings can be interpreted
in several ways. First, a critical threshold of parasite
obstruction ⁄ hypoxia is not exceeded that would induce
HIF expression and ⁄ or translocation to the nucleus of
cells within the brain. Direct observations of the rectal
microcirculation in southeast Asian adults with severe
malaria have shown remarkable heterogeneity in
microcirculatory blood ﬂow.
22 Vessels with little or
no blood ﬂow were often seen adjacent to vessels with
hyperdynamic ﬂow. This would result in a different
pattern of pathology from that of large vessel ischaemic
damage. Preserved ﬂow in adjacent capillaries may
cause a more gradual reduction in blood ﬂow, perhaps
with less hypoxia and substrate deprivation. Increased
vascular congestion in the cerebral microcirculation
with both infected and uninfected erythrocytes is a
hallmark of CM, which raises the interesting possibility
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during CM (Ponsford et al., in preparation). The con-
tribution of neuronal energy requirements to control of
local blood ﬂow and vascular architecture in the brain
may therefore be disrupted in CM by sequestration, a
potential cause of generalized neuronal dysfunction
and coma, without producing a picture of hypoxic
injury seen in a macrovascular pathology.
The expression of HIFs is strictly regulated, so it
cannot be ruled out that peak expression occurred
before the patients received treatment or before they
died. It should also be considered that destruction of
HIFs can occur independently of oxygen requirements
via a hydroxylation ⁄ ubiquitination ⁄ proteosome-inde-
pendent degradation pathway that is calpain-medi-
ated.
23 Elevated protein expression and distribution of
calpains are observed in these severe malaria cases.
8
Anticipating that HIF responses may be difﬁcult to
detect, we also examined other ‘footprints’ of hypoxia,
including downstream markers such as VEGF that can
be activated by HIF, and the transcriptional regulator
DEC-1 that is regulated by hypoxia and HIF-1a but is
more stable. DEC-1 labelling of nuclei was observed in
both controls and malaria cases, so HIF-1a stabilization
in the nucleus of cells in the brain at some point during
the disease course cannot be ruled out. There was a
trend for a greater frequency of DEC-1 immunoreac-
tivity in neurons in the brainstem compared with non-
neurological controls with multi-organ dysfunction,
but no difference was observed between CM and non-
CM cases, suggesting a general response to systemic
disease.
Studies of plasma levels of VEGF in southeast Asian
adults have shown counterintuitive results, with VEGF
concentrations lowest in severe malaria and inversely
associated with lactate.
13 The frequency of VEGF
protein expression in the brain of the severe malaria
cases was heterogeneous within groups, but extensive
labelling could be observed in neurons and glial cells in
severe malaria cases (Figures 2–4). This was not the
case for vascular-associated reactivity with median
levels <1% of the total number of vessels. Furthermore,
there was no signiﬁcant difference in the frequency of
VEGF labelling of any cell type between controls and
severe malaria cases and between CM and non-CM
cases. It should be emphasized that our immunohisto-
chemical data indicate the number of cells ⁄ vessels
containing VEGF protein and is not quantitative for the
total amount of VEGF protein produced by the cells.
Immunostaining may not detect soluble VEGF diffusing
into the parenchyma, and furthermore, no distinctions
can be made between systemic sources of VEGF that
have gained assess to the brain and been taken up by
resident brain cells, or VEGF bound to receptors but
produced by another cell locally or at a distance
initiating paracrine signalling. Our analysis of the
VEGF receptors suffers from similar limitations. How-
ever, erythropoietin (EPO) and its receptors also have
soluble and cell-associated forms but, in contrast, we
have found associations with potential hypoxia-induc-
ing stimuli.
30 Why these associations were not found
with VEGF is uncertain but may reﬂect the broader
range of stimuli that can up-regulate VEGF expression.
For example, picolinic acid is a non-hypoxic regulator
of VEGF protein expression
24 that is found in elevated
concentrations in the CSF of severe malaria patients.
25
In addition, there was no immunoreactivity of EPO in
parasites, so parasite manipulation of the VEGF
response could be inferred. Furthermore, it may be
the soluble form of VEGF rather than the cell-associated
form that is induced. In a rat model of global ischaemia
four VEGF isoforms were induced, but it was the
secreted isoform VEGF164 that dominated.
26
Dealing with such a complex disease and organ as
the brain we found the best way to determine whether
VEGF signalling is impacting the disease was to use
activation state-dependent antibodies. Only cells ⁄ ves-
sels with receptors exposed to sufﬁcient levels of ligand
to trigger autophosphorylation and subsequent signal-
ling would be visualized. Using a phosphorylated KDR
antibody, we have been able to show that the vascu-
lature and cells of the brain parenchyma show a high
frequency of VEGF signalling. Similar levels were also
found in neurons in the non-neurological controls with
multi-organ dysfunction without structural brain dam-
age, suggesting that this is a non-speciﬁc response to
severe disease. However, we could ascertain that
vascular-associated cells and parenchymal cells would
be receptive to VEGF signalling through KDR. There
were malaria-speciﬁc responses with a greater fre-
quency of signalling implied by pKDR immunoreactiv-
ity in the vasculature of severe malaria cases compared
with UK controls with multi-organ dysfunction, per-
haps providing greater cytoprotection in response to a
greater level of local microvascular insult. However,
there was no correlation with the amount parasite
sequestration at death.
Our group has previously shown labelling of para-
sites for VEGF in vitro and in vivo.
15 This study has
extended our initial ﬁndings by establishing the
patterns of VEGF+ parasites in different brain areas
within individual patients and by the ﬁnding that
VEGF+ parasites were primarily observed in cases with
high sequestration rates. The latter ﬁnding suggests
that VEGF is taken up when there is a critical threshold
of parasite density within a vessel. This threshold may
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having the lowest threshold and cortex the highest
(Figure 4). Whether VEGF+ parasites are observed
sequestered in other organs of these cases is currently
under investigation. Since sequestration could be
adequately assessed in the brain in only half of the
severe malaria cases and since only six of these cases
showed VEGF+ parasites, our correlative analysis with
clinical and biochemical markers was underpowered.
However, it has been established in these cases that
cerebral sequestration is inversely proportional to the
interval from admission to death and treatment effects
(Turner et al., in preparation), so the true incidence of
VEGF+ parasite reactivity in the brain during the
disease course is probably much higher than this study
suggests.
The pathological signiﬁcance of VEGF+ parasites is
unclear. Whether this represents a parasite response to
hypoxia is also unknown. The Plasmodium parasite is
microaerophilic in culture, and there may be some
survival advantage to the parasite in maintaining a low
oxygen environment during development. No parasite
homologues for VEGF were found on a Genbank search
of the 3D7 malaria genome. Similarly, the Plasmodium
parasite genome contains no homologues of HIF-1 or
the major proteins controlling oxygen sensing and
hypoxic gene regulation in mammalian cells, either at
the enzymatic level, including HIF prolyl hydroxylase
and factor inhibiting HIF, or the transcriptional level
(DEC-1) (observations from GenBank and Plasmodial
genome searches). Taken together with our in vitro
studies, it is most likely that the VEGF is of host origin.
At high levels of vessel sequestration there may be
increased soluble VEGF production by endothelial cells
and perivascular cells as a result of local hypoxia. The
sequestered parasites may interrupt autocrine or para-
crine signalling in endothelial cells by taking up the
VEGF. The uptake of circulating VEGF produced at a
distance cannot be ruled out. Whether the parasite
utilizes VEGF for its beneﬁt, or modulates signalling
through uptake or release of VEGF at schizogony is
unknown. However, there is in vitro evidence that
VEGF can be trophic for parasite growth and partially
protect them from the effects of drug treatment.
15
Impairment of circulating VEGF could contribute to the
impaired endothelial nitric oxide production and endo-
thelial dysfunction described in the severe malaria
study of Yeo et al.
13
In conclusion, the use of immunohistochemical
staining on autopsy tissues from severe malaria cases
is not an appropriate way to detect very short-lived and
transient patterns of the hypoxia-inducible transcrip-
tion factor protein expression. A complete lack of HIF
induction and ⁄ or translocation to the nucleus cannot
be ruled out, since we have observed expression of the
more stable DEC-1 that is both hypoxia- and HIF-1a-
regulated. The frequency of DEC-1 was not malaria
speciﬁc, with a similar distribution observed in UK
controls with multi-organ disease. Although our pre-
vious studies in these severe malaria cases have
demonstrated hypoxic-associated protein expression of
EPO and its receptors,
30 this was not the case for VEGF
and its receptors. This may reﬂect a broader range
of stimuli that can up-regulate VEGF expression.
However, EPO was not found to be associated with
sequestered malaria parasites. For our interpretation of
VEGF signalling we have relied on an activation-
speciﬁc antibody. Vascular and parenchymal cells
would be receptive to the actions of VEGF signalling
through KDR. A high frequency of labelling for pKDR
could be observed in malaria and controls, suggesting
this is a response to severe systemic disease. However,
signalling at the vasculature was statistically greater
in severe malaria cases, perhaps providing greater
cytoprotection in response to a greater level of
local injurious insult. The role of the sequestered
malaria parasite in these processes requires further
investigation.
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